Lithium carbonate is one of the most popular drug used in the bipolar disorders treatment

Bipolar Disorders are mental health conditions characterized by either of two contrasting phases namely, hypomania and hypersomnia. In an affected individual, the mood cycle between the two extremes is apparent. The sufferer exhibits mood cycling between acute episodes of depression and mania. For example, a depressive episode might follow by mild mania for about two weeks followed by a depressive episode which will subside and leave the sufferer back in a neutral phase. Bipolar Disorder symptoms manifest in adolescence or puberty as well as in adults. They can occur at any time in a person's life but the earlier the symptoms are detected, the better are the chances of successful treatment.

Bipolar Disorder Treatment Market

 

Bipolar Disorders have a significant impact on the lives of people who are afflicted with them. As there are no permanent or lasting solutions to Bipolar Disorders. Many families find it difficult to deal with the situation and are forced to make decisions for the affected family member concerning their livelihood, their relationships with other family members, and their participation in society. Bipolar Disorders are divided into two main subtypes. Bipolar I disorders are characterized by mood cycles that alternate between depressive and manic states. Bipolar II disorders are typified by a manic episode followed by depressive and/or hypomanic states. In addition to the two main types, a few unusual types of Bipolar Disorders have also been identified.

Lithium carbonate is one type of bipolar disorders treatment as this medication acts as an anti-depressant and is usually prescribed to patients who suffer from Bipolar II. Lithium carbonate is also effective in reducing the symptoms of manic episodes and preventing the occurrence of mania. Cognitive-behavioral therapy is another type of bipolar disorders treatment as it helps the affected person to identify the root cause of his or her Bipolar Disorder symptoms

Read More@https://www.globenewswire.com/news-release/2020/04/10/2014821/0/en/At-a-CAGR-of-5-2-Bipolar-Disorder-Treatment-Market-to-Surpass-US-10-925-5-Million-globally-by-end-of-2027-Says-CMI.html

Comments

Popular posts from this blog

Increasing Initiatives to Digitalize the Healthcare Sector Is Expected To Boost Demand for Electronic Medical Records

Ureteroscopes are highly preferred option over traditional ureteroscopy

Pharmacy Benefit Management is an Integral Part of the Medicare System